WORLD FDA approves first peanut allergy drug for children


FDA approves first peanut allergy drug for children


15:58, February 01, 2020

WASHINGTON, Jan. 31 (Xinhua) -- The U.S. Food and Drug Administration on Friday approved Palforzia, the first drug treatment for peanut allergy for children aged four to 17 years old.


File photo: CGTN

"Palforzia provides an FDA-approved treatment option to help reduce the risk of these allergic reactions in children with peanut allergy," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. Those who take Palforzia must continue to avoid peanuts in their diets.

Peanut allergy affects approximately one million children in the United States and only one out of five of these children will outgrow their allergy.

Palforzia is a powder manufactured from peanuts and packaged in pull-apart capsules and a sachet.

The powder is mixed with a small amount of semisolid food like yogurt, according to the FDA.

Palforzia is priced it at 890 U.S. dollars per month.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue